Detected ·
Orakl Oncology
$34MSeries A
Orakl Oncology raised $34M in Series A funding, co-led by Norrsken VC and Singular, to accelerate its AI-driven platform predicting cancer drug trial outcomes.
- Website
- —
- linkedin.com/company/85957194
- Amount
- $34 000 000 USD
- Stage
- Series A
- Event
- Funding round
- Detected
- 2026-11-12 14:51:16 UTC
- Signal ID
- b6afd74b-59b9-45e0-87df-0ad23dd2a1a6
As the API returns it
{
"id": "b6afd74b-59b9-45e0-87df-0ad23dd2a1a6",
"created_at": "2026-11-12T14:51:16.796575Z",
"company_name": "Orakl Oncology",
"company_website_url": null,
"company_linkedin_url": "https://www.linkedin.com/company/85957194",
"event_type": "funding",
"funding_amount": 34000000,
"funding_currency": "USD",
"funding_stage": "series_a",
"message": "*Orakl Oncology raised $34M in Series A funding, co-led by Norrsken VC and Singular, to accelerate its AI-driven platform predicting cancer drug trial outcomes.*"
}